Cancer Treatment Informed by the Molecular Tumor Board At Dartmouth
Phase 2
192
about 5.8 years
18+
1 site in NH
What this study is about
Researchers are testing whether treatment recommendations from a Molecular Tumor Board impact how doctors make decisions about cancer treatment at Dartmouth Cancer Center. The trial will involve patients whose tumors are genetically profiled and who meet specific eligibility criteria. Doctors will be asked to complete surveys about how the Molecular Tumor Board's evaluation influenced their treatment choices.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Treatment recommendations made by Molecular Tumor Board
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Secondary: Number of participants with progression-free survival after Molecular Tumor Board recommendations were made., Time to treatment failure
Oncology